417 related articles for article (PubMed ID: 18794711)
21. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.
Moravvej H; Razavi GM; Farshchian M; Malekzadeh R
Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
23. Mucocutaneous manifestations of inflammatory bowel disease in Turkey.
Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M
J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761
[TBL] [Abstract][Full Text] [Related]
24. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
Menachem Y; Gotsman I
Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
[TBL] [Abstract][Full Text] [Related]
25. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease?
Satta R; Pes GM; Rocchi C; Pes MC; Dore MP
J Dermatolog Treat; 2019 Sep; 30(6):612-616. PubMed ID: 30244616
[No Abstract] [Full Text] [Related]
26. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study.
Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792
[No Abstract] [Full Text] [Related]
27. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009.
Polcz M; Gu J; Florin T
J Crohns Colitis; 2011 Apr; 5(2):148-51. PubMed ID: 21453884
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis].
Tian Y; Li JX; Wang HH; Li RY; Liu XG
Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):505-9. PubMed ID: 27373283
[TBL] [Abstract][Full Text] [Related]
29. Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum.
Becker SL; Rios-Duarte JA; Morrison GM; Xia E; Mostaghimi A; Himed S; Kaffenberger BH; Zhang D; Shields BE; Cogen AL; Ortega-Loayza AG
Arch Dermatol Res; 2024 Mar; 316(4):98. PubMed ID: 38446235
[TBL] [Abstract][Full Text] [Related]
30. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
Károlyi Z; Erós N; Ujszászy L; Nagy G
Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
[TBL] [Abstract][Full Text] [Related]
31. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
[TBL] [Abstract][Full Text] [Related]
32. [Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum--presentation of two cases].
Wojas-Pelc A; Wielowieyska-Szybińska D; Setkowicz M; Szybiński P; Bogdaszewska-Czabanowska J
Przegl Lek; 2001; 58(10):945-9. PubMed ID: 11957826
[TBL] [Abstract][Full Text] [Related]
33. Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease.
Gellert A; Green ES; Beck ER; Ridley CM
Postgrad Med J; 1983 Dec; 59(698):791-3. PubMed ID: 6657543
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous manifestations in inflammatory bowel disease.
Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
[TBL] [Abstract][Full Text] [Related]
35. Dermatological signs during inflammatory bowel diseases.
Feliciani C; De Simone C; Amerio P
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():15-21. PubMed ID: 19530507
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
[TBL] [Abstract][Full Text] [Related]
37. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
38. Skin Manifestations of Inflammatory Bowel Disease.
Greuter T; Navarini A; Vavricka SR
Clin Rev Allergy Immunol; 2017 Dec; 53(3):413-427. PubMed ID: 28643285
[TBL] [Abstract][Full Text] [Related]
39. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.
Veloso FT; Carvalho J; Magro F
J Clin Gastroenterol; 1996 Jul; 23(1):29-34. PubMed ID: 8835896
[TBL] [Abstract][Full Text] [Related]
40. How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?
Hanauer SB
Inflamm Bowel Dis; 1998 Feb; 4(1):70; discussion 73. PubMed ID: 9552231
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
